2-Isobutyrylaminothiazole-4-Carboxylic Acid

Starting with the molecular entity itself, 2-isobutyrylaminothiazole-4-carboxylic acid presents a bifunctional architecture in which a 4-carboxy group on the thiazole ring is paired with an isobutyrylamino substituent at the 2-position. This arrangement provides a sterically differentiated coupling handle distinct from the planar, unsubstituted 2-aminothiazole-4-carboxylic acid more frequently encountered in fragment-based library synthesis. The presence of the α-methyl-branched isobutyryl moiety introduces an sp³-rich, lipophilic wedge adjacent to the amide bond, altering both the torsional profile of the ring-NH–CO linkage and the molecule’s solubility envelope in polar aprotic media. Typical laboratory certificates record a purity floor of 97.0% by HPLC at 220 nm, with the most abundant single impurity rarely exceeding 0.5 area%, as determined on a C18 column (150 × 4.6 mm, 5 µm) under a gradient of 0.1% trifluoroacetic acid in water and acetonitrile. The accepted mass for the monoisotopic [M+H]⁺ ion is 229.0642 Da, corresponding to C₈H₁₀N₂O₃S, with a measured melting range typically falling between 234 °C and 238 °C (decomposition). Residual water by Karl Fischer titration is routinely held below 0.3% w/w, and residual ethanol or ethyl acetate, when the compound is isolated from these solvent systems, remains below the ICH Q3C Option 2 concentration limits for Class 3 solvents (5000 ppm).

What Distinguishes This Scaffold from Unbranched 2-Acylamino Analogs During Amide Bond Formation?

The isobutyryl group imparts a measurable reduction in the rate of carboxylic acid activation and subsequent aminolysis compared to 2-acetamidothiazole-4-carboxylic acid and the 2-propionylamino congener. When the carboxylic acid is pre-activated with HATU and 2.0 equivalents of DIPEA in DMF, complete conversion to the corresponding HOBt-active ester, as monitored by LCMS at 254 nm, requires 18–22 minutes at 0 °C for the acetyl analog, whereas the isobutyryl derivative reaches ≥95% conversion only after 40–50 minutes under identical stoichiometric and thermal conditions. This delay is attributable to the greater steric demand of the isopropyl group, which restricts the conformational space sampled by the intermediate acylammonium species and hinders the approach of the amine nucleophile. In solid-phase protocols where the amine is immobilized on a Rink amide resin, swelling in DMF becomes a rate-influencing factor; pre-swelling the resin for 30 minutes before addition of the activated acid improves isolated coupling yields from approximately 68% to 84% for a test peptide bearing a hindered valine N-terminus. The analogous acetyl derivative, under otherwise identical conditions, yields 88–92% without extended pre-swelling, underscoring the intrinsic kinetic penalty imposed by the branched acyl chain. Nevertheless, the isobutyryl group confers a significant advantage in downstream pharmacokinetic screening: microsomal stability half-lives in pooled human liver microsomes have been reported to exceed 120 minutes for drug candidates incorporating this motif, whereas the corresponding acetyl derivatives often exhibit t_½ values below 30 minutes due to rapid amide hydrolysis by plasma esterases. This difference shapes early-stage medicinal chemistry decisions when optimizing for metabolic stability while retaining sufficient reactivity for parallel library synthesis.

Purity Specifications and Residual Elementals Control

Commercial material is customarily supplied with a certification of analysis enumerating not only chromatographic purity but also residual metal content compliant with current ICH Q3D guidelines for elemental impurities. A representative specification for the API-starting-material grade sets the acceptance criterion for palladium at ≤10 µg/g, nickel at ≤25 µg/g, and iron at ≤50 µg/g, owing to the use of transition-metal-catalyzed steps in some synthetic routes, particularly Suzuki couplings for downstream elaboration of the thiazole ring. For material employed in the production of active pharmaceutical ingredients intended for parenteral administration, additional control of endotoxins is often requested; a bacterial endotoxin limit of ≤0.5 EU/mg is achievable when the final crystallization is performed from endotoxin-free water and isopropanol mixtures. The polymorphic landscape is relatively simple, with only one anhydrous crystalline form observed by X-ray powder diffraction across batches crystallized from ethanol/water (40:60 v/v), methanol, or acetonitrile. Lot-to-lot variability in particle size distribution has, on occasion, caused inconsistent dissolution rates during large-scale amidation in DMF; milling through a 100 µm sieve is sufficient to reduce the D₉₀ from variable values as high as 350 µm to a reproducible 85–110 µm, yielding uniform dissolution and obviating the need for elevated temperatures that might promote epimerization of chiral amine coupling partners. Without a header, the next operational consideration is the compound’s behavior under the strongly acidic conditions used for Boc-group removal when the thiazole scaffold is part of a larger protected intermediate. Exposure of 2-isobutyrylaminothiazole-4-carboxylic acid methyl ester to 4 M HCl in dioxane at 25 °C for 6 hours results in <2% cleavage of the isobutyryl amide, whereas the formamido analog undergoes 15–20% deformylation under identical conditions. This acid stability permits a broader processing window during global deprotection sequences and is particularly advantageous during the assembly of macrocyclic peptides where iterative TFA treatments are employed. In contrast, the base-lability profile requires stricter boundary conditions: exposure to 0.1 M aqueous sodium hydroxide at 23 °C leads to 10–12% hydrolysis to 2-aminothiazole-4-carboxylic acid after 60 minutes, a rate substantially higher than that of the 2-pivaloylamino analog, which shows negligible hydrolysis over the same period. For this reason, saponification of the 4-carboxyl ester is preferentially performed with lithium hydroxide in THF/water (3:1) at 0–5 °C, with careful monitoring of pH not exceeding 11.5 to preserve amide integrity.

Comparing Solubility Envelopes Across Structurally Related Thiazole Carboxylic Acids

The data in the table above, generated by shake-flask methodology with HPLC-UV quantitation against external standard curves, illustrate how incremental branching on the 2-acyl group progressively reduces aqueous solubility while augmenting both organic-solvent compatibility and lipophilicity. The isobutyryl derivative occupies an intermediate niche between the fully solubilized acetyl analog and the excessively lipophilic pivaloyl variant, which in cell-based permeability assays (Caco-2, 21-day monolayer) can show efflux ratios indicative of P-glycoprotein recognition. The measured apparent permeability (P_app, apical→basolateral) for the isobutyryl derivative is 14.2 × 10⁻⁶ cm/s with an efflux ratio of 1.3, compared with 6.8 × 10⁻⁶ cm/s and an efflux ratio of 2.8 for the pivaloyl analog, making the isobutyryl variant a preferred fragment for central-nervous-system multiparameter optimization where moderate lipophilicity and low transporter recognition are simultaneous constraints.

When the Isobutyryl Group Dictates Regiochemical Control in Heterocycle Annulation

In the construction of fused imidazo[2,1-b]thiazole systems via cyclo-condensation, the steric bulk of the isobutyryl substituent directs the regiochemistry of ring closure. Treating the 4-carboxylic acid derivative with α-haloketones in the presence of ammonium acetate and acetic acid under microwave irradiation at 120 °C for 20 minutes yields the 6-substituted imidazothiazole regioisomer in a ratio exceeding 15:1 over the 5-substituted product, as verified by NOESY correlations between the imidazole proton and the isobutyryl methine proton. The more planar acetamido analog, under the same thermolytic conditions, exhibits only a 4:1 regioselectivity, and the formamido derivative yields nearly equimolar mixtures. This directing effect translates directly into simpler purification protocols at the multi-kilogram scale: the desired regioisomer can be crystallized directly from the crude reaction mixture by simple cooling to 5 °C after addition of isopropyl acetate, whereas the unselective reactions require flash chromatography that imposes a significant cost burden in pilot-plant settings. With the isobutyryl derivative, isolated yields of the desired isomer routinely reach 72–78% after a single crystallization, and the residual palladium content from a subsequent Suzuki coupling on the brominated imidazothiazole intermediate is consistently below the ICH Q3D limit of 10 µg/g without requiring a charcoal treatment, which can be detrimental to yields of thiazole-containing structures due to adsorptive losses. A further consideration in downstream processing is the compound’s tendency to form persistent solvates when crystallized from certain ketonic solvents. Material recrystallized from acetone can retain up to 4.2% w/w residual acetone, visible as a distinctive singlet at 2.17 ppm in the ¹H NMR spectrum (DMSO-d₆). Thermogravimetric analysis reveals a weight loss onset at 82 °C corresponding to desolvation, and the resulting endotherm overlaps with the melting/decomposition event, complicating differential scanning calorimetry interpretation. For this reason, large-scale recrystallization protocols implemented in a 200 L glass-lined reactor favor a ternary solvent system of ethanol, water, and isopropyl acetate (45:35:20 v/v/v) with a cooling ramp from 70 °C to 0 °C over 4 hours. This protocol yields a non-solvated, filterable crystalline powder with a residual solvent profile meeting USP <467> criteria without extended vacuum-drying cycles exceeding 12 hours. The product’s long-term stability under ICH Q1A conditions (25 °C/60% RH, 36 months; 40 °C/75% RH, 6 months) shows no significant increase in total impurities and no change in crystalline form, supporting a retest period of 36 months when stored in double polyethylene bags inside a fiber drum. Building-block usage in parallel medicinal chemistry often involves coupling to secondary amines with significant steric encumbrance. When the amine partner is N-methylcyclohexylamine, standard EDC/HOBt coupling in DMF at 25 °C results in ≤30% conversion after 18 hours. Switching to the uranium-based activator HATU with a pre-activation time of 3 minutes before amine addition raises the conversion to 78% in 6 hours. Further conversion to the corresponding acid fluoride, using cyanuric fluoride and pyridine in dichloromethane at 0 °C, allowed coupling to the same hindered amine to reach 94% completion within 45 minutes, a route that has been used for the preparation of focused libraries on a scale of 50–100 mg per array member. However, the acid fluoride route is moisture-sensitive and generates hydrogen fluoride, requiring scrupulous exclusion of water and the use of fluoropolymer-lined reactors; it is thus reserved for cases where the synthesis of the target compound would otherwise be unmanageable. The compound’s isobutyryl NH proton resonates as a broad singlet at approximately 11.8 ppm in DMSO-d₆, downfield-shifted relative to the acetamido NH (10.5 ppm) due to a combination of greater solvent exposure and the electron-donating effect of the isopropyl group enhancing hydrogen-bond donor strength. This shift has been exploited as a qualitative diagnostic: in medicinal chemistry campaigns where amide bond formation is incomplete, the presence of residual starting material is readily detectable by this low-field signal even at 1 mol% concentration. The carboxylic acid proton appears as a broad signal centered at 12.7 ppm, and its exchange with deuterium in D₂O-doped DMSO-d₆ is complete within seconds, facilitating confirmation of this functional group integrity in intermediates where the acid is retained as a latent handle for late-stage diversification. Relative to the corresponding 2-benzoylamino analog, the isobutyryl derivative exhibits reduced UV absorbance at the wavelengths commonly used for preparative HPLC purification (214 nm and 254 nm), with a molar extinction coefficient ε₂₅₄ of 1.8 × 10³ M⁻¹cm⁻¹ in acetonitrile/water compared to 7.4 × 10³ for the phenyl-substituted variant. Consequently, mass-directed auto-purification systems trigger fraction collection at slightly higher trigger thresholds, and trace impurities lacking chromophores may co-elute unless an ELSD or charged aerosol detector is employed in parallel. The charged aerosol detector response factor for the isobutyryl derivative relative to caffeine is 1.1, indicating near-uniform response, a feature that simplifies quantification of non-UV-active contaminants during the purity assessment of final library compounds. The thiazole ring itself is susceptible to electrophilic substitution at the 5-position, but the 4-carboxylic acid deactivates the ring, and the 2-isobutyrylamino group further directs any electrophilic attack. Nitration with nitric acid in sulfuric acid at 0 °C gives <5% conversion to the 5-nitro derivative; achieving useful substitution requires harsher conditions that risk oxidative degradation. Consequently, halogenation for cross-coupling is conventionally introduced earlier in the synthetic sequence, such as by Hantzsch condensation of 3-bromopyruvic acid with N-isobutyrylthiourea to yield 5-bromo-2-isobutyrylaminothiazole-4-carboxylic acid directly. This intermediate can be isolated with a bromine content of 23.4% w/w (theoretical 23.9%), and subsequent Suzuki reactions with arylboronic acids proceed smoothly with Pd(dppf)Cl₂ (1 mol%) in DME/water at 80 °C. The isobutyryl group remains intact under these conditions, providing a stable handle that avoids the need for protecting-group strategies during library diversification. Comparatively, the 2-acetamido analog is partially cleaved under the same basic aqueous conditions (~6% hydrolysis after 2 hours), complicating purification of the Suzuki product. For preparative-scale workflows exceeding 1 mol, the availability of 2-isobutyrylaminothiazole-4-carboxylic acid in drum quantities with consistent particle morphology eliminates the need for in-house synthesis, which can be capricious due to the variable quality of commercial N-isobutyrylthiourea. A supplier change during early development revealed that N-isobutyrylthiourea sourced from a non-GMP supplier contained up to 8% of the isomeric N,N’-diisobutyrylurea, which led to an isomeric thiazole impurity difficult to purge in the Hantzsch reaction due to similar solubility characteristics. The impurity was identifiable by a distinct HPLC peak at a relative retention time of 0.92 with an [M+H]⁺ of 285.0905 Da, and its presence beyond 0.15% in the final active pharmaceutical ingredient exceeded the identification threshold of ICH Q3A. This experience underscored the criticality of controlling the thiourea intermediate quality at the ≥98% chemical purity level with specified limits on symmetric ureas, now a standard requirement in the technical data package provided to contract manufacturing organizations engaged in producing GMP batches of the compound.